(Reuters) - Merck & Co said on Tuesday it will advance its
experimental Alzheimer's drug into late-stage trials among patients with
mild to moderate disease, after an independent monitoring board
reviewed its safety and recommended the trial continue to recruit
patients.
AlzheimeResearch.com | Finding a cure for Alzheimer's disease
Showing posts with label blocking beta secretase. Show all posts
Showing posts with label blocking beta secretase. Show all posts
Subscribe to:
Posts (Atom)